About

Allison Fulton is a partner in the Life Sciences and FDA team and is based in the firm's Washington, D.C. office.

Latest Post

With a September 24, 2022 compliance date looming, the U.S. Food and Drug Administration (FDA) announced that will delay enforcement of its requirement to submit Unique Device Identifier (UDI) data for low-risk consumer health products. Consumer health products, as described in the FDA guidance, include class 1 devices that are typically sold directly to consumers, such as digital health products and consumables. The FDA guidance extends the compliance date for data submission from September 24, 2022 to December 8, 2022, giving manufacturers of consumer health products more time to prepare their submissions.

Continue Reading FDA Delays Enforcement of UDI Reporting Requirements for Consumer Health Products

About

Allison Fulton is a partner in the Life Sciences and FDA team and is based in the firm's Washington, D.C. office.

Subscribe: Subscribe via RSS